Organon & Co. (OGN)

Healthcare · Drug Manufacturers General · NYSE

Organon & Co. (OGN) is a Healthcare company in the Drug Manufacturers General industry. It has a market capitalization of $3.60B, a trailing price-to-earnings ratio of 4.3 and a free-cash-flow yield of 10.7%. Over the most recent reported fiscal year, revenue declined 2.9% and free cash flow per share fell 35.1%.

Market cap	$3.60B
Trailing P/E	4.3
FCF yield	10.7%
Revenue growth (YoY)	-2.9%
EPS growth (YoY)	-10.9%
FCF/share growth (YoY)	-35.1%
Exchange	NYSE
Sector	Healthcare
Industry	Drug Manufacturers General

Explore live OGN data on Nama Insights →

Recent Congressional trades

Organon & Co. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Kevin Hern	House	Sell	$1,001 - $15,000	Aug 12, 2026
Kevin Hern	House	Sell	$1,001 - $15,000	Aug 10, 2026